12:00 AM
 | 
Oct 14, 2013
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Metabolic Solutions preclinical data

In a mouse model of PD, MSDC-0160 improved motor deficits, restored neurotransmitter levels in the striatum and protected dopaminergic neurons in the substantia nigra. Data were presented at the Grand Challenges...

Read the full 132 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >